These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
433 related items for PubMed ID: 20506162
1. Reversing interleukin-2 inhibition mediated by anti-double-stranded DNA autoantibody ameliorates glomerulonephritis in MRL-lpr/lpr mice. Song YC, Tang SJ, Lee TP, Hung WC, Lin SC, Tsai CY, Ng WV, Wu MF, Sun KH. Arthritis Rheum; 2010 Aug; 62(8):2401-11. PubMed ID: 20506162 [Abstract] [Full Text] [Related]
2. Monoclonal anti-double-stranded DNA antibodies cross-react with phosphoglycerate kinase 1 and inhibit the expression and production of IL-2 in activated Jurkat T cell line. Luan HY, Tang SJ, Yang W, Tsai CY, Sun GH, Sun KH. Clin Immunol; 2006 Sep; 120(3):326-34. PubMed ID: 16857429 [Abstract] [Full Text] [Related]
3. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S. J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011 [Abstract] [Full Text] [Related]
4. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis. Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A. Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253 [Abstract] [Full Text] [Related]
5. B7 costimulation in the development of lupus: autoimmunity arises either in the absence of B7.1/B7.2 or in the presence of anti-b7.1/B7.2 blocking antibodies. Liang B, Gee RJ, Kashgarian MJ, Sharpe AH, Mamula MJ. J Immunol; 1999 Aug 15; 163(4):2322-9. PubMed ID: 10438978 [Abstract] [Full Text] [Related]
6. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus. Eivazova ER, McDonnell JM, Sutton BJ, Staines NA. Arthritis Rheum; 2000 Feb 15; 43(2):429-39. PubMed ID: 10693885 [Abstract] [Full Text] [Related]
7. Arginines in the CDR of anti-dsDNA autoantibodies facilitate cell internalization via electrostatic interactions. Song YC, Sun GH, Lee TP, Huang JC, Yu CL, Chen CH, Tang SJ, Sun KH. Eur J Immunol; 2008 Nov 15; 38(11):3178-90. PubMed ID: 18991292 [Abstract] [Full Text] [Related]
8. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice. Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A. Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074 [Abstract] [Full Text] [Related]
9. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus. Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A. J Rheumatol; 2010 Jan 15; 37(1):60-70. PubMed ID: 19955044 [Abstract] [Full Text] [Related]
10. Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies. Riemekasten G, Langnickel D, Ebling FM, Karpouzas G, Kalsi J, Herberth G, Tsao BP, Henklein P, Langer S, Burmester GR, Radbruch A, Hiepe F, Hahn BH. Arthritis Rheum; 2003 Feb 15; 48(2):475-85. PubMed ID: 12571858 [Abstract] [Full Text] [Related]
11. Inhibition of (S)-armepavine from Nelumbo nucifera on autoimmune disease of MRL/MpJ-lpr/lpr mice. Liu CP, Tsai WJ, Shen CC, Lin YL, Liao JF, Chen CF, Kuo YC. Eur J Pharmacol; 2006 Feb 15; 531(1-3):270-9. PubMed ID: 16413531 [Abstract] [Full Text] [Related]
12. Inhibition of superantigen-induced proinflammatory cytokine production and inflammatory arthritis in MRL-lpr/lpr mice by a transcriptional inhibitor of TNF-alpha. Edwards CK, Zhou T, Zhang J, Baker TJ, De M, Long RE, Borcherding DR, Bowlin TL, Bluethmann H, Mountz JD. J Immunol; 1996 Aug 15; 157(4):1758-72. PubMed ID: 8759766 [Abstract] [Full Text] [Related]
13. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B. J Am Soc Nephrol; 2005 Dec 15; 16(12):3592-601. PubMed ID: 16267157 [Abstract] [Full Text] [Related]
14. Aberrant expression pattern of histone acetylation modifiers and mitigation of lupus by SIRT1-siRNA in MRL/lpr mice. Hu N, Long H, Zhao M, Yin H, Lu Q. Scand J Rheumatol; 2009 Dec 15; 38(6):464-71. PubMed ID: 19922023 [Abstract] [Full Text] [Related]
15. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. Lartigue A, Colliou N, Calbo S, François A, Jacquot S, Arnoult C, Tron F, Gilbert D, Musette P. J Immunol; 2009 Nov 15; 183(10):6207-16. PubMed ID: 19841185 [Abstract] [Full Text] [Related]
16. Preferential dependence of autoantibody production in murine lupus on CD86 costimulatory molecule. Nakajima A, Azuma M, Kodera S, Nuriya S, Terashi A, Abe M, Hirose S, Shirai T, Yagita H, Okumura K. Eur J Immunol; 1995 Nov 15; 25(11):3060-9. PubMed ID: 7489744 [Abstract] [Full Text] [Related]
17. Treatment with testosterone or estradiol in melatonin treated females and males MRL/MpJ-Faslpr mice induces negative effects in developing systemic lupus erythematosus. Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P, Rubio A, Guerrero JM, Osuna C. J Pineal Res; 2008 Sep 15; 45(2):204-11. PubMed ID: 18507713 [Abstract] [Full Text] [Related]
18. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice. Lichtnekert J, Rupanagudi KV, Kulkarni OP, Darisipudi MN, Allam R, Anders HJ. J Immunol; 2011 Sep 15; 187(6):3413-21. PubMed ID: 21849682 [Abstract] [Full Text] [Related]
19. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production. Kawamoto M, Harigai M, Hara M, Kawaguchi Y, Tezuka K, Tanaka M, Sugiura T, Katsumata Y, Fukasawa C, Ichida H, Higami S, Kamatani N. Arthritis Res Ther; 2006 Sep 15; 8(3):R62. PubMed ID: 16563187 [Abstract] [Full Text] [Related]
20. Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice. Radvanyi LG, Raju K, Spaner D, Mills GB, Miller RG. Cell Immunol; 1998 Jan 10; 183(1):1-12. PubMed ID: 9578714 [Abstract] [Full Text] [Related] Page: [Next] [New Search]